

Author: Brusentsov N. Polyanskii V. Pirogov Yu. Dubina A. Uchevatkin A. Kupriyanov D. Tishchenko D. Nikitin P. Brusentsova T. Ksenevich T. Nikitin M. Vol’ter E. Ivanov A.
Publisher: Springer Publishing Company
ISSN: 0091-150X
Source: Pharmaceutical Chemistry Journal, Vol.44, Iss.6, 2010-10, pp. : 291-295
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Fe3O4 nanoparticles were coated with a layer of citric acid, forming coordination bonds between citrate ions and iron ions. The resulting aqueous citrate ferrite colloid was used as a T2-weighted MRI negative contrasting agent. Sequential i.v. doses of citrate ferrite and Magnevist led to increases in MRI image contrast for 40 h and brightness for 30 min; scanning using a Bruker Biospec BC 70/30 USR biospectrotomograph yielded enhanced MRI images. This enhancement of MRI images was used to monitor oncogenesis during magnetohydrodynamic thermochemotherapy (MT) of mammary adenocarcinoma Ca 755 in female C57Bl/6j mice. Dextran ferrite colloid containing cyclophosphamide was tested as a magnetically directed antitumor agent using MT. Treatment of non-infiltrating tumors of volume ≍ 30 mm3 with six sessions of MT each lasting 30 min at 46°C led to 40% tumor regression and 300% increases in survival time. Treatment of infiltrating tumors of volume ≍ 300 mm3 in the same conditions yielded a 200% increase in survival time.
Related content






Magnetic resonance imaging in cardiology
By Bellenger Nick Pennell Dudley
Clinical Medicine, Vol. 33, Iss. 1, 1999-01 ,pp. :


Coronary Magnetic Resonance Imaging
Current Pharmaceutical Design, Vol. 14, Iss. 18, 2008-06 ,pp. :


In Vitro and In Vivo Antitumor Effects of Bisphosphonates
Current Medicinal Chemistry, Vol. 10, Iss. 2, 2003-01 ,pp. :